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 Teaching cardiovascular medicine to machines 
Pablo Lamata  https://doi.org/10.1093/cvr/cvy127  
Engineers and researchers are boosting human induction and deduction skills assisted by computers, 
and this is one of the main drivers of progress in cardiovascular sciences and healthcare. This claim 
builds on two core ideas: machine learning 1 as the vehicle for inductive reasoning, and computational 
cardiac models 2 as the tool for deductive reasoning, both illustrated in Fig. 1. 
 
Fig. 1: Conceptual representation of the synergy between mechanistic and statistical computational models as the pathway 
towards precision medicine. 
Machine learning refers to the ability of computers to gain knowledge without being explicitly 
programmed for it: the computer extracts patterns from the data, and thus “learns” a statistical model 
that will perform a given task (i.e. disease classification and prediction 3 or segment the myocardium 
in an image 4). The logic process followed here is inductive, since the machine makes broad 
generalizations from specific observations it has learned from. The availability of new sources of data 
(i.e. omics or continuous monitoring systems), the digitalization of the health record, and the recent 
advances in machine learning technology now offer the opportunity to reveal new patterns, new 
signatures of cardiovascular health and disease 1. 
On the other hand, computational cardiac models are the representations of our knowledge of the 
physiology of the heart pump and circulatory system governed by fundamental laws of physics and 
biochemistry. Computers are explicitly programmed to represent this knowledge into mechanistic 
models, and use them to perform a given task (i.e. estimate myocardial stiffness 5, identify the fibrosis 
patterns that lead to persistent re-entrant drivers in atrial fibrillation 6, or compute the risk of drug 
toxicity 7). The logic process followed here is deductive, since the machine reaches conclusions based 
on the concordance of multiple premises and assumptions. The availability of rich anatomical and 
functional data and the recent advances in computational cardiology technology now offer, through 
the process of model personalization, two opportunities: the ability to present an integral and 
cohesive diagnostic picture of the patient, and the possibility to simulate and predict the evolution of 
a condition or the impact of a treatment 2,8. 
Both statistical and mechanistic models are thus rendering very encouraging perspectives and 
expectations, but these should be handled with caution.  
Machine learning, as a tool for inductive reasoning, does not provide us with a conclusive proof of 
causal connections. Accordingly, the patterns observed in the data will not necessary continue to exist 
in the future (or simply in other studies or individual cases). This translates into the specific problem 
of the generalizability of the model learned, which is in compromise with its complexity (that is, in 
essence, the number of features or parameters to be learned from the data). As a consequence, if the 
problem to be solved requires a large number of features in order to make accurate predictions, then 
many more training examples are needed to ensure a valid generalization. 
Computational cardiac models, as tools for deductive reasoning, rely on the validity of the premises 
and assumptions they are built on. Models are always a simplification of the reality, we simply can’t 
capture the entire complexity of the natural world. Consequently, the biomarkers and predictions 
extracted from models will always have a degree of uncertainty caused by the impact of assumptions 
and of the limitations of the data inputted into the model. And similarly with statistical models, 
mechanistic models present a compromise between complexity and uncertainty: the larger the 
number of model parameters the problem requires to make accurate predictions, the richer the 
dataset from an individual patient is required to ensure a valid personalised estimation. 
An exciting perspective is the combination of inductive and deductive reasoning of statistical and 
mechanistic models. Machine learning can be informed by the features learned from mechanistic 
models 9. Our knowledge or the cardiovascular system is vast and should definitely guide the 
identification of valid data pieces to build the optimal statistical model. Revisiting the physical 
principles that underpin key clinical decisions can improve the accuracy and precision of well 
recognised diagnostic biomarkers used in clinical guidelines, such as the pressure gradient caused by 
aortic stenosis 10.  
On the other hand, statistical models can be built from a population of mechanistic models 11, and 
mechanistic explanations can originate from, or can validate, the findings of statistic models - an 
example is the identification of the anatomical signature of heart failure to predict response to cardiac 
resynchronization therapy 12. Arguably the most attractive area of synergy between statistical and 
mechanistic models is the redefinition of patient classes, with early success stories in hypertrophic 
cardiomyopathy based on the ECG phenotype 13, in heart failure with preserved ejection fraction 14, 
or the proposal of the three main mechanistic substrates that explain the potential impact of a 
resynchronization therapy in heart failure 15.  
Guidelines and quality assurance in this emerging field is an important consideration. Medical devices 
that do not have any precedent are much more challenging to get regulatory approval, and there are 
early cases of success in this process such as the prediction of the fractional flow reserve using 
mechanistic simulations 16. Earlier in the research process, analysis standards and reporting guidelines 
help the field to mature as a discipline, where an excellent example is the Comprehensive In vitro 
Proarrhythmia Assay initiative 17.  
My personal vision is that the most significant impact will be the solution of the tension between 
clinical guidelines and the actual decisions with each individual patient: machine learning, equipped 
with the right population data, will identify the most relevant existing cases (similar to the individual) 
to trigger the inductive reasoning; computational cardiac models, equipped with the right data of the 
individual patient, will identify of the most sensible set of plausible parameters (those that explain the 
data of the subject) to trigger the deductive reasoning; and their combination will be the actual 
pathway towards the concept of the precision medicine 18, where computational tools will assist the 
cardiologists in the definition of the optimal diagnosis and therapy planning for the individual patient. 
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